Jeffrey A. Chodakewitz

Jeffrey A. Chodakewitz, M.D. has extensive experience holding leadership positions in the bio-pharmaceutical industry. Most recently, Jeff served as Executive Vice President, Clinical Medicine and External Innovation, at Vertex Pharmaceuticals. Prior to that role, he held the roles of Chief Medical Officer and Executive Vice President, Global Medicines Development and Medical Affairs at Vertex from January 2014 to April 2018 and was a member of the Vertex Executive Committee. Prior to Vertex, Jeff spent over 20 years at Merck & Co., where he served in a number of leadership positions including Head of Infectious Diseases and Vaccines Global Development, Senior Vice President of Global Scientific Strategy (Infectious Disease, Respiratory & Immunology), Vice President of Early Stage Development and Senior Vice President of Late Stage Development. Jeff currently serves on the boards of Tetraphase Pharmaceuticals, Inc. (TTPH), resTORbio (TORC) and Freeline Therapeutics. He holds a B.S in Biochemistry cum laude from Yale University and an M.D. from the Yale University School of Medicine.